Buying Wegovy at the 1.7mg Maintenance Dose: Your Legal Route in the UK

Your consultation with nume is free, with no hidden fees at any stage, one transparent price covers everything.
A GPhC-registered Independent Prescriber reads your answers personally, the same day you submit, not software, not a queue.
Order before noon on a working day and, once clinically approved, your treatment leaves our pharmacy the same afternoon.
DPD delivers to your door the next working day, tracked and in plain, unbranded packaging, at no extra cost.

The 1.7mg dose of Wegovy is a penultimate step on the standard titration path — reached after several months on lower doses and used by many people as a stepping stone to the 2.4mg maintenance dose. In the UK, Wegovy is a prescription-only medicine, which means the only legal route to it is a clinical assessment with a qualified prescriber. There are no shortcuts, and there shouldn't be. If you're at this dose or approaching it, the process matters as much as the medicine itself — and getting it right protects both your safety and your supply.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the decision to move to 1.7mg is made, and how to get there safely

What reaching 1.7mg actually means for your treatment

Wegovy's titration schedule exists for a reason. The body needs time to adjust to semaglutide, and the lower doses (0.25mg, 0.5mg, 1.0mg) are stages in that adjustment, not therapeutic targets in themselves. If you want to read about the early stages before committing to a higher dose, you can find out more about how the 0.5mg step-up dose fits into the titration journey. The 1.7mg dose sits just below the standard maximum maintenance dose of 2.4mg. Reaching it means your prescriber has reviewed your progress and side-effect experience at earlier stages and judged the increase appropriate.

That clinical judgement is not a formality. The prescriber looks at how you've tolerated previous doses, whether any gastrointestinal side effects have settled, and whether your weight-management goals are being supported. Some people stay at 1.7mg for longer than the minimum titration window if that dose is working well and tolerance is still establishing. Others move on to 2.4mg on schedule. Either decision belongs to you and your prescriber, not to a fixed timetable.

If you're exploring what the full dose pathway looks like, our Wegovy overview page sets out the licensed schedule and what each stage is designed to do.

The legal route to 1.7mg: prescription first, every time

Wegovy is a Prescription-Only Medicine under the Human Medicines Regulations 2012. That classification applies to every dose, including 1.7mg. No pharmacy in the UK (physical or online) can legally supply it to you without a valid prescription issued after a genuine clinical assessment. The NHS covers semaglutide for weight management in specific circumstances, but access through NHS specialist services typically involves long waiting periods, and the criteria are strict. Many people who are clinically suitable choose a regulated private route instead.

The private route works like this: you complete a clinical consultation, a qualified prescriber reviews your information and medical history, and if Wegovy is appropriate for you at the requested dose, a prescription is issued. The pharmacy then dispenses and delivers your treatment. Every step has a regulatory footing. You can verify any online pharmacy on the GPhC pharmacy register before you hand over any personal information. That check takes under a minute: search by name or registration number and confirm the pharmacy's status is active. It's a simple habit, and one that matters.

NHS England's guidance on weight management injections explains both the NHS and private pathways clearly if you want to understand the full landscape before deciding.

The risk of buying Wegovy without a prescription

The MHRA has issued repeated warnings about counterfeit weight-loss pens sold through social media and unverified online sellers. In 2025 enforcement operations seized approximately 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million, and the first UK site manufacturing fake tirzepatide pens was raided. Fake pens have been found to contain no active medicine at all, or in some cases dangerously wrong substances. The consequences for patients have included hospitalisations.

Red flags to watch for: any seller offering Wegovy at the 1.7mg dose or any other strength without requiring a prescription; prices that sit dramatically below the private market; discount codes offered as incentives; and no visible GPhC registration. If you encounter any of these, you can report the seller directly via the MHRA Yellow Card scheme, which accepts reports of both suspect medicines and suspect sellers. The same scheme is there if you want to report a side effect from any medicine.

For a fuller picture of what a safe supply chain looks like versus what to avoid, the prescription requirements for Wegovy page covers the regulatory detail.

How nume handles a 1.7mg request

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber. If you're already on Wegovy at an earlier dose and moving to 1.7mg, our prescribers ask for evidence of your current treatment, this is standard clinical practice and a safeguard against inappropriate dose escalation. If you're transferring from another provider, the same applies: your prescriber needs to know what you've been taking and how you've responded.

Once your consultation is reviewed and a prescription is issued, your treatment is dispatched the same day (for orders submitted before noon on a working day) and arrives with DPD the next working day. There's no subscription and no auto-renewal. Every repeat order goes through a fresh clinical review before anything is sent. Our clinical team oversees every prescription personally.

If you'd like to understand where 1.7mg sits relative to the final step, the 2.4mg maintenance dose page explains what the move to that level typically involves. And if you're earlier in the titration process, the 1.0mg step-up page covers the preceding stage. When you're ready, you can order Wegovy 1.7mg through our regulated consultation process directly, no referral needed, no waiting list.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions